SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001437749-19-023309
Filing Date
2019-11-20
Accepted
2019-11-20 19:00:00
Documents
2
Period of Report
2019-11-18

Document Format Files

Seq Description Document Type Size
1 FORM 4 rdgdoc.html 4  
1 FORM 4 rdgdoc.xml 4 3619
2 yedidpoa.htm EX-24 6583
  Complete submission text file 0001437749-19-023309.txt   11891
Mailing Address 290 UTAH AVE., SUITE 200 SOUTH SAN FRANCISCO CA 94080
Business Address 290 UTAH AVE., SUITE 200 SOUTH SAN FRANCISCO CA 94080 (650) 550-3500
Vaxart, Inc. (Issuer) CIK: 0000072444 (see all company filings)

IRS No.: 591212264 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O LIFESCI ADVISORS 250 WEST 55TH STREET, SUITE 3401 NEW YORK NY 10019
Business Address
Yedid Robert A. (Reporting) CIK: 0001792558 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35285 | Film No.: 191235372